Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > New nanodevice defeats drug resistance: Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs

At left is the new nanodevice, consisting of a hydrogel embedded with gold nanoparticles coated with DNA targeting a gene called MRP-1. At right, the device fluoresces after encountering the target gene sequence.

Courtesy of the researchers
At left is the new nanodevice, consisting of a hydrogel embedded with gold nanoparticles coated with DNA targeting a gene called MRP-1. At right, the device fluoresces after encountering the target gene sequence.

Courtesy of the researchers

Abstract:
Chemotherapy often shrinks tumors at first, but as cancer cells become resistant to drug treatment, tumors can grow back. A new nanodevice developed by MIT researchers can help overcome that by first blocking the gene that confers drug resistance, then launching a new chemotherapy attack against the disarmed tumors.

New nanodevice defeats drug resistance: Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs

Cambridge, MA | Posted on March 2nd, 2015

The device, which consists of gold nanoparticles embedded in a hydrogel that can be injected or implanted at a tumor site, could also be used more broadly to disrupt any gene involved in cancer.

"You can target any genetic marker and deliver a drug, including those that don't necessarily involve drug-resistance pathways. It's a universal platform for dual therapy," says Natalie Artzi, a research scientist at MIT's Institute for Medical Engineering and Science (IMES), an assistant professor at Harvard Medical School, and senior author of a paper describing the device in the Proceedings of the National Academy of Sciences the week of March 2.

To demonstrate the effectiveness of the new approach, Artzi and colleagues tested it in mice implanted with a type of human breast tumor known as a triple negative tumor. Such tumors, which lack any of the three most common breast cancer markers -- estrogen receptor, progesterone receptor, and Her2 -- are usually very difficult to treat. Using the new device to block the gene for multidrug resistant protein 1 (MRP1) and then deliver the chemotherapy drug 5-fluorouracil, the researchers were able to shrink tumors by 90 percent in two weeks.

Overcoming resistance

MRP1 is one of many genes that can help tumor cells become resistant to chemotherapy. MRP1 codes for a protein that acts as a pump, eliminating cancer drugs from tumor cells and rendering them ineffective. This pump acts on several drugs other than 5-fluorouracil, including the commonly used cancer drug doxorubicin.

"Drug resistance is a huge hurdle in cancer therapy and the reason why chemotherapy, in many cases, is not very effective", says Joăo Conde, an IMES postdoc and lead author of the PNAS paper.

To overcome this, the researchers created gold nanoparticles coated with strands of DNA complementary to the sequence of MRP1 messenger RNA -- the snippet of genetic material that carries DNA's instructions to the rest of the cell.

These strands of DNA, which the researchers call "nanobeacons," fold back on themselves to form a closed hairpin structure. However, when the DNA encounters the correct mRNA sequence inside a cancer cell, it unfolds and binds to the mRNA, preventing it from generating more molecules of the MRP1 protein. As the DNA unfolds, it also releases molecules of 5-fluorouracil that were embedded in the strand. This drug then attacks the tumor cell's DNA, since MRP1 is no longer around to pump it out of the cell.

"When we silence the gene, the cell is no longer resistant to that drug, so we can deliver the drug that now regains its efficacy," Conde says.

When each of these events occurs -- sensing the MRP1 protein and releasing 5-fluorouracil -- the device emits fluorescence of different wavelengths, allowing the researchers to visualize what is happening inside the cells. Because of this, the particles could also be used for diagnosis -- specifically, determining if a certain cancer-related gene is activated in tumor cells.

Controlled drug release

The DNA-coated gold nanoparticles are embedded in an adhesive gel that stays in place and coats the tumor after being implanted. This local administration of the particles protects them from degradation that might occur if they were administered throughout the body, and also enables sustained drug release, Artzi says.

In their mouse studies, the researchers found that the particles could silence MRP1 for up to two weeks, with continuous drug release over that time, effectively shrinking tumors.

This approach could be adapted to deliver any kind of drug or gene therapy targeted to a specific gene involved in cancer, the researchers say. They are now working on using it to silence a gene that stimulates gastric tumors to metastasize to the lungs.

###

Graduate student Nuria Oliva is also an author of the paper. The research was funded by the National Cancer Institute and a Marie Curie International Outgoing Fellowship.

####

For more information, please click here

Contacts:
Sarah McDonnell

617-253-8923

Copyright © Massachusetts Institute of Technology

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Deca Partners with ADTEC Engineering to Enhance Adaptive Patterning™ for 2µm Chiplet Scaling October 20th, 2020

Graphenea awarded “Best Graphene Firm” prize October 20th, 2020

Veeco Announces Aledia Order of 300mm MOCVD Equipment for microLED Displays: Propel™ Platform First 300mm System with EFEM Designed for Advanced Display Applications October 20th, 2020

Revealing the reason behind jet formation at the tip of laser optical fiber October 16th, 2020

Cancer

'Like a fishing net,' nanonet collapses to trap drug molecule: New method presents possibilities for rapidly making and testing vaccine formulations October 6th, 2020

Secure nano-carrier delivers medications directly to cells:Nanoparticles with synthetic DNA can control release of active agents September 25th, 2020

Dipanjan Pan demonstrates new method to produce gold nanoparticles in cancer cells: Possible applications in x-ray imaging, cancer treatment September 11th, 2020

Silver-plated gold nanostars detect early cancer biomarkers: New optical sensing platform can detect genomic cancer biomarkers directly in patient tissues July 24th, 2020

Govt.-Legislation/Regulation/Funding/Policy

NSF renews Rice-based NEWT Center for water treatment: Partnership primed to introduce game-changing technologies to address global needs October 15th, 2020

New NIST project to build nano-thermometers could revolutionize temperature imaging: Cheaper refrigerators? Stronger hip implants? A better understanding of human disease? All of these could be possible October 9th, 2020

Graphene detector reveals THz light's polarization October 8th, 2020

Multi-institutional team extracts more energy from sunlight with advanced solar panels October 6th, 2020

Nanomedicine

Octopus-inspired sucker transfers thin, delicate tissue grafts and biosensors October 16th, 2020

Controlling the speed of enzyme motors brings biomedical applications of nanorobots closer: Recent advances in this field have made micro- and nanomotors promising devices for solving many biomedical problems October 13th, 2020

New drug carrier systems: University of Delaware researchers advance drug delivery systems to treat connective tissue disorders October 9th, 2020

HKU Engineering team develops novel miniaturised organic semiconductor: An important breakthrough essential for future flexible electronic devices October 8th, 2020

Discoveries

Revealing the reason behind jet formation at the tip of laser optical fiber October 16th, 2020

Multi-state data storage leaving binary behind: Stepping 'beyond binary' to store data in more than just 0s and 1s October 16th, 2020

Octopus-inspired sucker transfers thin, delicate tissue grafts and biosensors October 16th, 2020

Controlling the speed of enzyme motors brings biomedical applications of nanorobots closer: Recent advances in this field have made micro- and nanomotors promising devices for solving many biomedical problems October 13th, 2020

Announcements

Deca Partners with ADTEC Engineering to Enhance Adaptive Patterning™ for 2µm Chiplet Scaling October 20th, 2020

Graphenea awarded “Best Graphene Firm” prize October 20th, 2020

Veeco Announces Aledia Order of 300mm MOCVD Equipment for microLED Displays: Propel™ Platform First 300mm System with EFEM Designed for Advanced Display Applications October 20th, 2020

GLOBALFOUNDRIES Accelerating Innovation in IoT and Wearables with Adaptive Body Bias Feature on 22FDX Platform October 16th, 2020

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters

Making disorder for an ideal battery: Manufacturing safer, more powerful batteries that use geopolitically stable resources requires solid electrolytes and replacing lithium with sodium. A chemical solution is now being offered to battery developers. October 16th, 2020

Revealing the reason behind jet formation at the tip of laser optical fiber October 16th, 2020

Multi-state data storage leaving binary behind: Stepping 'beyond binary' to store data in more than just 0s and 1s October 16th, 2020

Octopus-inspired sucker transfers thin, delicate tissue grafts and biosensors October 16th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project